BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2162802)

  • 1. [Differential lung cancer diagnosis--progress or fiasco?].
    Müller KM
    Fortschr Med; 1990 Apr; 108(11):17-9. PubMed ID: 2162802
    [No Abstract]   [Full Text] [Related]  

  • 2. Small cell lung cancer presenting as a Pancoast tumor.
    Lands RH; Patel N; Maran S; Karnad A
    J Tenn Med Assoc; 1991 Mar; 84(3):113-4. PubMed ID: 1648650
    [No Abstract]   [Full Text] [Related]  

  • 3. [Transbronchial biopsy of the lung in the diagnosis of peripheral cancer and diffuse-disseminated processes].
    Lebedev VA; Blinchevskiĭ ID
    Sov Med; 1990; (9):107-11. PubMed ID: 2176348
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
    Lyda MH; Weiss LM
    Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clonogenic culture of identified cells of lung tumors and correlation with certain histopathologic aspects of the tumor mass].
    Gotzos V; Hahnloser P; Petropoulos P
    Helv Chir Acta; 1991 Feb; 57(5):725-9. PubMed ID: 1650768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the percutaneous biopsy in the evolving diagnosis and treatment of lung cancer.
    Barnes D; Souza C; Entwisle J
    Clin Radiol; 2010 Nov; 65(11):951-2. PubMed ID: 20933653
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problem cases in lung pathology].
    Müller KM
    Pathologe; 1996 Jan; 17(1):98-101. PubMed ID: 8685105
    [No Abstract]   [Full Text] [Related]  

  • 8. Galectin-3: differential expression between small-cell and non-small-cell lung cancer.
    Buttery R; Monaghan H; Salter DM; Sethi T
    Histopathology; 2004 Apr; 44(4):339-44. PubMed ID: 15049899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Small cell bronchial cancer--pathologic anatomy].
    Müller KM; Fisseler-Eckhoff A
    Langenbecks Arch Chir Suppl Kongressbd; 1991; ():534-43. PubMed ID: 1665368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.
    Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M
    Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of the cut-off value of serum neuron-specific enolase in differentiating small cell lung cancer from non-small cell lung cancer].
    Wei T; Luo RC; Zuo Q; Zhang JY; Miao JX; Lu HF
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):858-9. PubMed ID: 16793621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lung tumours under the microscope].
    Wiechmann V
    MMW Fortschr Med; 2007 Nov; 149(44):27-9. PubMed ID: 18078166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical study of RAS oncoprotein in cytologic specimens of primary lung tumours.
    Koutselini H; Kappatou G; Yiagnisis M; Field JK; Spandidos DA
    Anticancer Res; 1990; 10(3):597-603. PubMed ID: 2164347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined large cell neuroendocrine, small cell and squamous carcinomas of the lung with rhabdoid cells.
    Chetty R
    Pathology; 2000 Aug; 32(3):209-12. PubMed ID: 10968398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nuclear morphometry by image analysis in the histopathologic diagnosis of lung cancer.
    Kavantzas N; Lazaris AC; Chatzigianni E; Davaris PS
    J Exp Clin Cancer Res; 2000 Jun; 19(2):201-6. PubMed ID: 10965819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Cyfra 21-1 as a marker for lung cancer.
    Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R
    Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology of lung cancer.
    Carney DN
    Bull Cancer; 1987; 74(5):495-500. PubMed ID: 2825849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody that distinguishes small-cell lung cancer from non-small-cell lung cancer.
    Watanabe J; Okabe T; Fujisawa M; Takaku F; Hirohashi S; Shimosato Y
    Cancer Res; 1987 Feb; 47(3):826-9. PubMed ID: 3026618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of tumor markers in lung biopsies and in bronchial lavage].
    Vogel J; Loos U; Oehr P
    Pneumologie; 1990 Feb; 44 Suppl 1():465-6. PubMed ID: 2164199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.